Guerbet
http://dbpedia.org/resource/Guerbet an entity of type: Thing
Guerbet ist ein auf Kontrastmittel spezialisiertes Pharmaunternehmen mit Sitz in Villepinte, nordöstlich von Paris. Das Unternehmen beschäftigt nach eigenen Angaben weltweit etwa 2700 Mitarbeiter und ist im CAC Small gelistet.
rdf:langString
Guerbet est une entreprise pharmaceutique française créée en 1926. Elle est cotée à la bourse de Paris.
rdf:langString
Guerbet (Euronext: GBT) is a France-based manufacturer of contrast agents used in medical imaging. The company was founded in 1926 by André Guerbet, the son of Marcel Guerbet who in 1901 discovered Lipiodol – the first iodinated X-ray contrast agent. In 2017 Guerbet’s revenues were €807.1 million. It employs over 2,700 people worldwide and has manufacturing facilities in France, Ireland, Canada, Macedonia, the United States and Brazil. The company’s headquarters are located in Villepinte, a suburb of Paris and its shares are included in the CAC Small stock index.
rdf:langString
rdf:langString
Guerbet
rdf:langString
Guerbet
rdf:langString
Guerbet
xsd:integer
13706713
xsd:integer
1100304005
rdf:langString
Guerbet ist ein auf Kontrastmittel spezialisiertes Pharmaunternehmen mit Sitz in Villepinte, nordöstlich von Paris. Das Unternehmen beschäftigt nach eigenen Angaben weltweit etwa 2700 Mitarbeiter und ist im CAC Small gelistet.
rdf:langString
Guerbet (Euronext: GBT) is a France-based manufacturer of contrast agents used in medical imaging. The company was founded in 1926 by André Guerbet, the son of Marcel Guerbet who in 1901 discovered Lipiodol – the first iodinated X-ray contrast agent. In 2017 Guerbet’s revenues were €807.1 million. It employs over 2,700 people worldwide and has manufacturing facilities in France, Ireland, Canada, Macedonia, the United States and Brazil. The company’s headquarters are located in Villepinte, a suburb of Paris and its shares are included in the CAC Small stock index. In July 2015, Guerbet announced the takeover of Mallinckrodt's contrast media and application systems divisions. The acquisition was completed in November 2015.
rdf:langString
Guerbet est une entreprise pharmaceutique française créée en 1926. Elle est cotée à la bourse de Paris.
xsd:nonNegativeInteger
1585